Cargando…
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
BACKGROUND: Metastatic uveal melanoma is a highly fatal disease; most patients die from their hepatic metastasis within 1 year. A major drawback in the development of new treatments for metastatic uveal melanoma is the difficulty in obtaining appropriate cell lines and the lack of appropriate animal...
Autores principales: | Kageyama, Ken, Ohara, Masahiro, Saito, Kengo, Ozaki, Shinji, Terai, Mizue, Mastrangelo, Michael J., Fortina, Paolo, Aplin, Andrew E., Sato, Takami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481921/ https://www.ncbi.nlm.nih.gov/pubmed/28645290 http://dx.doi.org/10.1186/s12967-017-1247-z |
Ejemplares similares
-
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
por: Ohara, Masahiro, et al.
Publicado: (2021) -
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
por: Sugase, Takahito, et al.
Publicado: (2020) -
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2020)